The Indonesian government has replaced imported COVID-19 vaccines with domestically produced ones that have lower chances of side effects, according to .
The year 2022 marked a new chapter in the journey of the pharmaceutical industry in the country by showcasing the ability to produce domestic vaccines amid .
President Joko Widodo has said that he is impressed by the pharmaceutical industry, which has pursued the development of a COVID-19 vaccine using an mRNA .
Indonesia has secured a chance to produce an mRNA (messenger RNA) vaccine through the technology transfer of AWcorna vaccine, which is currently ongoing, .
AWcorna becomes the first mRNA COVID-19 vaccine trademark to be developed and produced in Indonesia, Food and Drug Supervisory Agency (BPOM) Head Penny K. .